These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 17505926

  • 21. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K, Boulle A, Coetzee D, Abrams EJ, Myer L.
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [Abstract] [Full Text] [Related]

  • 22. A national study of the relationship of care site HIV specialization to early adoption of highly active antiretroviral therapy.
    Wilson IB, Landon BE, Ding L, Zaslavsky AM, Shapiro MF, Bozzette SA, Cleary PD.
    Med Care; 2005 Jan; 43(1):12-20. PubMed ID: 15626929
    [Abstract] [Full Text] [Related]

  • 23. Comparing total health care costs and treatment patterns of HIV patients in a managed care setting.
    Purdum AG, Johnson KA, Globe DR.
    AIDS Care; 2004 Aug; 16(6):767-80. PubMed ID: 15370064
    [Abstract] [Full Text] [Related]

  • 24. An exploration of factors influencing adherence to highly active anti-retroviral therapy (HAART) among people living with HIV/AIDS in Northern Thailand.
    Ruanjahn G, Roberts D, Monterosso L.
    AIDS Care; 2010 Dec; 22(12):1555-61. PubMed ID: 20582752
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.
    Quentin W, König HH, Schmidt JO, Kalk A.
    Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185
    [Abstract] [Full Text] [Related]

  • 28. An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART.
    Jelsma J, Maclean E, Hughes J, Tinise X, Darder M.
    AIDS Care; 2005 Jul; 17(5):579-88. PubMed ID: 16036244
    [Abstract] [Full Text] [Related]

  • 29. Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model.
    Harries AD, Gomani P, Teck R, de Teck OA, Bakali E, Zachariah R, Libamba E, Mwansambo A, Salaniponi F, Mpazanje R.
    Trans R Soc Trop Med Hyg; 2004 Dec; 98(12):695-701. PubMed ID: 15485699
    [Abstract] [Full Text] [Related]

  • 30. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS.
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [Abstract] [Full Text] [Related]

  • 31. The societal burden of HIV/AIDS in Northern Italy: an analysis of costs and quality of life.
    Hubben GA, Bishai D, Pechlivanoglou P, Cattelan AM, Grisetti R, Facchin C, Compostella FA, Bos JM, Postma MJ, Tramarin A.
    AIDS Care; 2008 Apr; 20(4):449-55. PubMed ID: 18449822
    [Abstract] [Full Text] [Related]

  • 32. Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy).
    Farmer P, Léandre F, Mukherjee J, Gupta R, Tarter L, Kim JY.
    Bull World Health Organ; 2001 Apr; 79(12):1145-51. PubMed ID: 11799447
    [Abstract] [Full Text] [Related]

  • 33. Are public antenatal clinics in Blantyre, Malawi, ready to offer services for the prevention of vertical transmission of HIV?
    Misiri HE, Tadesse E, Muula AS.
    Afr J Reprod Health; 2004 Aug; 8(2):64-70. PubMed ID: 15623120
    [Abstract] [Full Text] [Related]

  • 34. The social construction of ARVs in South Africa.
    Sember R.
    Glob Public Health; 2008 Aug; 3 Suppl 2():58-75. PubMed ID: 19288353
    [Abstract] [Full Text] [Related]

  • 35. [Factors associated with adherence to therapy among HIV-infected patients in Bangui].
    Mouala C, Kaba-Mebri J, Wata JB, Rey JL.
    Sante; 2006 Aug; 16(2):119-30. PubMed ID: 17116636
    [Abstract] [Full Text] [Related]

  • 36. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
    de Brito LC, da Rosa MA, Lopes VS, e Ferreira EF, Vieira LQ, Sobrinho AP.
    J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
    [Abstract] [Full Text] [Related]

  • 37. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [Abstract] [Full Text] [Related]

  • 38. Assessment of the prevalence of distal symmetrical polyneuropathy and its risk factors among HAART-treated and untreated HIV infected individuals.
    Shurie JS, Deribew A.
    Ethiop Med J; 2010 Apr; 48(2):85-93. PubMed ID: 20608012
    [Abstract] [Full Text] [Related]

  • 39. Outpatient pharmacy care and HIV viral load response among patients on HAART.
    Castillo E, Palepu A, Beardsell A, Akagi L, Yip B, Montaner JS, Hogg RS.
    AIDS Care; 2004 May; 16(4):446-57. PubMed ID: 15203413
    [Abstract] [Full Text] [Related]

  • 40. Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAART.
    Stoll M, Claes C, Schulte E, Graf von der Schulenburg JM, Schmidt RE.
    Eur J Med Res; 2002 Nov 25; 7(11):463-71. PubMed ID: 12568973
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.